RSS

Acute Kidney Injury (AKI)

Pfizer has acquired a minority equity interest in AM-Pharma, a privately held Dutch biopharma company focused on the development of recAP for inflammatory diseases, and secured an exclusive option to acquire the remaining equity in the company. more

News